10-carboxymethyl-9-acridanone has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, XL; You, QD; Zhang, H | 1 |
| Bai, H; Gao, Y; Geng, M; Li, Z; Niu, J; Wang, X; Xie, Z; Xu, Y; Yang, Y; Zhang, Y; Zhou, B | 1 |
1 review(s) available for 10-carboxymethyl-9-acridanone and Benign Neoplasms
| Article | Year |
|---|---|
Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Autoimmune Diseases; Binding Sites; Chemistry, Pharmaceutical; Drug Delivery Systems; Humans; Membrane Proteins; Neoplasms; Protein Structure, Secondary; Signal Transduction | 2020 |
1 other study(ies) available for 10-carboxymethyl-9-acridanone and Benign Neoplasms
| Article | Year |
|---|---|
Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration.
Topics: 14-alpha Demethylase Inhibitors; Humans; Imidazoles; Immunity, Innate; Immunotherapy; Membrane Proteins; Neoplasms | 2022 |